| Item Type | Name |
|
Academic Article
|
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
|
|
Academic Article
|
Treatment controversies in medulloblastoma.
|
|
Academic Article
|
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
|
|
Academic Article
|
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
|
|
Academic Article
|
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.
|
|
Academic Article
|
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
|
|
Academic Article
|
Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
|
|
Academic Article
|
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
|
|
Academic Article
|
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
|
|
Academic Article
|
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
|
|
Academic Article
|
Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma.
|
|
Academic Article
|
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
|
|
Academic Article
|
Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
|
|
Academic Article
|
Medulloblastoma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors in a child: case report.
|
|
Academic Article
|
Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
|
|
Academic Article
|
Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study.
|
|
Academic Article
|
Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.
|
|
Academic Article
|
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
|
|
Academic Article
|
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
|
|
Academic Article
|
FOXG1 dysregulation is a frequent event in medulloblastoma.
|
|
Academic Article
|
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
|
|
Academic Article
|
Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
|
|
Concept
|
Medulloblastoma
|
|
Academic Article
|
Implications of tumor location on subtypes of medulloblastoma.
|
|
Academic Article
|
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.
|
|
Academic Article
|
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
|
|
Academic Article
|
Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma.
|
|
Academic Article
|
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.
|
|
Academic Article
|
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.
|
|
Academic Article
|
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
|
|
Academic Article
|
Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
|
|
Academic Article
|
DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors.
|
|
Academic Article
|
Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
|
|
Academic Article
|
Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
|
|
Academic Article
|
Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma.
|
|
Academic Article
|
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
|
|
Academic Article
|
Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.
|
|
Academic Article
|
Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma.
|
|
Academic Article
|
Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency.
|
|
Academic Article
|
Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
|
|
Academic Article
|
Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
|
|
Academic Article
|
Reply to S.A. Milgrom et al.
|
|
Academic Article
|
Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
|
|
Academic Article
|
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
|
|
Academic Article
|
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
|
|
Academic Article
|
Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
|
|
Academic Article
|
Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis.
|
|
Academic Article
|
Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
|
|
Academic Article
|
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
|
|
Academic Article
|
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
|
|
Academic Article
|
Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
|
|
Academic Article
|
Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma.
|
|
Academic Article
|
Adaptive, behavioral, and emotional outcomes following postoperative pediatric cerebellar mutism syndrome in survivors treated for medulloblastoma.
|